Epithelioid inflammatory myofibroblastic sarcoma responsive to surgery and an ALK inhibitor in a patient with panhypopituitarism.
Intern Med
; 53(19): 2211-4, 2014.
Article
em En
| MEDLINE
| ID: mdl-25274232
ABSTRACT
We encountered a case of epithelioid inflammatory myofibroblastic sarcoma (EIMS) originating from an abdominal organ that rapidly regrew twice. The patient underwent two surgeries. Large tumors grew within three months after the second surgery. The patient subsequently received chemotherapy with an anaplastic lymphoma kinase (ALK) inhibitor. Although EIMS has a poor prognosis, the patient continues to be alive with disease 14 months after surgical treatment and the administration of the ALK inhibitor.
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Sarcoma
/
Receptores Proteína Tirosina Quinases
/
Inibidores Enzimáticos
/
Hipopituitarismo
/
Neoplasias Intestinais
/
Laparotomia
Tipo de estudo:
Diagnostic_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limite:
Adult
/
Humans
/
Male
Idioma:
En
Ano de publicação:
2014
Tipo de documento:
Article